Abstract Details
|
Lawrence W. Elmer, MD, PhD
PRESENTER |
Dr. Elmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia Pharmaceuticals. Dr. Elmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Elmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. Dr. Elmer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Elmer has received research support from Vaccinex, Inc.. The institution of Dr. Elmer has received research support from Cynapsus Therapeutics, Inc.. The institution of Dr. Elmer has received research support from Lundbeck Pharmaceuticals, Inc.. The institution of Dr. Elmer has received research support from Intec Pharmaceuticals, Inc.. The institution of Dr. Elmer has received research support from Pharma Two B. The institution of Dr. Elmer has received research support from Acadia Pharmaceuticals, Inc.. The institution of Dr. Elmer has received research support from Impax Laboratories, LLC. The institution of Dr. Elmer has received research support from Prilenia Therapeutics. The institution of Dr. Elmer has received research support from Neuraly, Inc.. |
| Mahnaz Asgharnejad, PharmD (Takeda Pharmaceuticals) | Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Lars Bauer, MD (UCB Biosciences GmbH) | No disclosure on file |